Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran

被引:60
|
作者
Abbaszadegan, MR
Gholamin, M
Tabatabaee, A
Farid, R
Houshmand, M
Abbaszadegan, M
机构
[1] Mashhad Univ Med Sci, Bu Ali Res Inst, Dept Human Genet, Mashhad 91966, Iran
[2] Mashhad Univ Med Sci, Ghaem Univ Hosp, Immunol Res Ctr, Mashhad 91966, Iran
[3] Natl Genet Engn Res Inst, Tehran, Iran
[4] Arizona State Univ, Tempe, AZ 85287 USA
关键词
D O I
10.1128/JCM.41.6.2593-2595.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The city of Mashhad is the capital of Khorasan, the northeastern province of Iran, which has been recognized as an area where human T-lymphotropic virus type I (HTLV-1) infection is endemic. All serum samples from blood donors are routinely screened for HTLV-1 by using enzyme-linked immunosorbent assay (ELISA). In the present study, 28,926 donors (81.86% male and 18.14% female) with a mean age of 32 years (range, 18 to 65 years) were screened in a 6 months period (July to December 1999). Of these donors in the primary screening, 228 (0.78%) tested positive by ELISA. The positive samples were confirmed by Western blot (WB) analysis. The WB results indicated that, of 228 positive ELISA specimens, 91.2% (208 specimens) were HTLV-1, 4.82% (11 specimens) were HTLV, 3.5% (8 specimens) were indeterminate, and 0.44% (1 specimen) was not confirmed. HTLV refers to samples in which the complete viral antigen banding patterns on WB strips were not present. In order to further evaluate the detection methodologies used, the HTLV-1-seropositive samples, the indeterminant samples, and/or HTLV samples were examined and confirmed by PCR. The HTLV samples were determined to be HTLV-1, the remaining samples were indeterminant, and the negative sample could not be confirmed for HTLV-1 by PCR. The prevalence of HTLV-1 infection in our study was 0.77% among blood bank donors, which reconfirms the city of Mashhad as an area where the virus is endemic compared to other regions in the world. The incidence was correlated with increasing age, and it was higher in females than in males.
引用
收藏
页码:2593 / 2595
页数:3
相关论文
共 50 条
  • [11] Human T-Lymphotropic Virus Type 1 in Blood Donors from Babol County Blood Transfusion Center: A Pilot Study From Northern Iran
    Yahyapour, Yousef
    Aghajanipour, Kazem
    Mir, Seyed Mostafa
    Khademian, Aynaz
    Sadeghi, Farzin
    [J]. JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2017, 10 (09)
  • [12] The prevalence of human T-lymphotropic virus type 1 & 2 (HTLV-1/2) in South African blood donors
    Vermeulen, Marion
    Sykes, Wendy
    Coleman, Charl
    Custer, Brian
    Jacobs, Genevieve
    Jaza, Jabulisile
    Kaidarova, Zhanna
    Hlela, Carol
    Gessain, Antoine
    Cassar, Olivier
    Poole, Colwyn
    Ingram, Charlotte
    Murphy, Edward L.
    Reddy, Ravi
    [J]. VOX SANGUINIS, 2019, 114 (05) : 451 - 458
  • [13] Distribution of human T-lymphotropic virus type I among blood donors: A nationwide Brazilian study
    GalvaoCastro, B
    Loures, L
    Rodriques, LGM
    Ferreira, OC
    Franco, LGP
    Muller, M
    Sampaio, DA
    Santana, A
    Passos, LM
    Proietti, F
    [J]. TRANSFUSION, 1997, 37 (02) : 242 - 243
  • [14] Prevalence of antibodies to human T-lymphotropic virus types I and II among Saudi Arabian blood donors
    Al Jaouni, SK
    [J]. ANNALS OF SAUDI MEDICINE, 2000, 20 (02) : 155 - 156
  • [15] Human T-lymphotropic virus type I among blood donors from Guadeloupe: donation, demographic, and biologic characteristics
    Rouet, F
    Foucher, C
    Rabier, M
    Gawronski, I
    Taverne, D
    Chancerel, B
    Casman, O
    Strobel, M
    [J]. TRANSFUSION, 1999, 39 (06) : 639 - 644
  • [16] The Prevalence of Human T-Lymphotropic Virus Infection among Blood Donors in Southeast China, 2004-2013
    Xie, Jinzhen
    Ge, Shengxiang
    Zhang, Yali
    Lin, Yongcai
    Ni, Hongying
    Zhang, Jun
    Chen, Changrong
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2015, 9 (04):
  • [17] EPIDEMIOLOGY OF HUMAN T-LYMPHOTROPIC VIRUS I/II AMONG BLOOD DONORS IN TAIWAN
    Tsai, T.
    Lin, K. H.
    Chu, C.
    Lin, K. T.
    Hung, C. M.
    Lin, K. S.
    [J]. VOX SANGUINIS, 2009, 97 : 117 - 117
  • [18] Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in Israel
    Stienlauf, Shmuel
    Yahalom, Vered
    Shinar, Eilat
    Sidi, Yechezkel
    Segal, Gad
    Schwartz, Eli
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2013, 17 (11) : E1022 - E1024
  • [19] Prevalence of human T-lymphotropic virus type 1 and 2 infection in Sweden
    Malm, Kerstin
    Ekermo, Bengt
    Hillgren, Kristina
    Britton, Sven
    Fredlund, Hans
    Andersson, Soren
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 44 (11) : 852 - 859
  • [20] Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors
    Carvalho, EM
    Bacellar, O
    Porto, AF
    Braga, S
    Galvao-Castro, B
    Neva, F
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 27 (01) : 1 - 6